Foamix Pharmaceuticals to Present at the Barclays Global Healthcare Conference 2018

On March 8, Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX), ("Foamix"), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to address unmet needs in dermatology, reported that David Domzalski, Chief Executive Officer, will present a corporate overview and business update at the Barclays Global Healthcare Conference 2018, taking place March 13-15 at the Lowe’s Miami Beach Hotel in Miami, Florida (Press release, Foamix, MAR 8, 2018, View Source [SID1234524539]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Barclays Global Healthcare Conference 2018
Date: Wednesday, March 14
Time: 10:45am Eastern Time
Location: Lowe’s Miami Beach Hotel
Webcast: https://cc.talkpoint.com/barc002/031318a_as/?entity=42_2H5CIPS